Igor Koralnik to Retrospective Studies
This is a "connection" page, showing publications Igor Koralnik has written about Retrospective Studies.
Connection Strength
0.770
-
SARS-CoV-2-Specific Immune Responses in Patients With Postviral Syndrome After Suspected COVID-19. Neurol Neuroimmunol Neuroinflamm. 2023 11; 10(6).
Score: 0.120
-
Reader Response: A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021 03 16; 96(11):550.
Score: 0.101
-
Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients. Ann Clin Transl Neurol. 2020 11; 7(11):2221-2230.
Score: 0.098
-
Predictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy. J Neurovirol. 2016 08; 22(4):464-71.
Score: 0.070
-
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis. Ann Neurol. 2014 Jun; 75(6):925-34.
Score: 0.063
-
Hyperintense cortical signal on magnetic resonance imaging reflects focal leukocortical encephalitis and seizure risk in progressive multifocal leukoencephalopathy. Ann Neurol. 2014 May; 75(5):659-69.
Score: 0.063
-
The spectrum of neurological disorders in a Zambian tertiary care hospital. J Neurol Sci. 2010 Mar 15; 290(1-2):1-5.
Score: 0.047
-
Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology. 2006 Jan 24; 66(2):262-4.
Score: 0.035
-
Clinical presentation and outcomes of syphilitic meningitis among hospitalized adults in lusaka, Zambia. Int J STD AIDS. 2022 10; 33(12):1038-1044.
Score: 0.028
-
Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. Geroscience. 2022 06; 44(3):1241-1254.
Score: 0.027
-
Patient Income Does Not Predict Disability or Mortality in Hospitalized COVID-19 Patients in a Large Health Care System in the Chicago Metropolitan Area. J Health Care Poor Underserved. 2022; 33(3):1215-1229.
Score: 0.027
-
Abnormal movements in hospitalized COVID-19 patients: A case series. J Neurol Sci. 2021 04 15; 423:117377.
Score: 0.025
-
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate. J Neurol. 2020 01; 267(1):125-131.
Score: 0.023
-
Treatment of natalizumab-associated PML with filgrastim. Ann Clin Transl Neurol. 2019 May; 6(5):923-931.
Score: 0.022
-
Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 06 01; 75(2):246-255.
Score: 0.019